This book provides radiologists and oncologists with a working knowledge of, and a comprehensive set of excellent-quality images of, the various types of pelvic cancer.
This is a book review of MRI Manual of Pelvic Cancer by P.A. Hulse and B.M. Carrington, published by Martin Dunitz in 2004. It describes the book as a 251-page work compiled to give radiologists and oncologists a working knowledge of the various types of pelvic cancer, together with a set of images of those cancers. The review notes that most pelvic cancer is diagnosed on clinical examination supplemented by cystoscopy, colposcopy, or sigmoidoscopy, and that MRI has been used increasingly in the initial assessment of pelvic tumors.
The review states that the book has 14 chapters: the first three deal with pelvic anatomy, MRI techniques, and the role of MRI in diagnosis and staging, and other chapters cover cancer arising from various intrapelvic locations, with MR images demonstrating primary cancer, metastatic nodes, and stages based on the TNM staging system. It also describes images of diagnostic pitfalls, recurrent cancer, findings after chemotherapy or radiotherapy, MRI before exenteration, and imaging of metastatic cancer within the pelvis. The reviewer, E. Edmund Kim, MD, of the University of Texas M.D. Anderson Cancer Center, calls the book well organized and profusely illustrated, notes that the references are somewhat scanty, and says it is intended as a bench reference for radiologists and oncologists but is also useful for trainees.
| Publisher | Martin Dunitz |
|---|---|
| Publication year | 2004 |
| Pages | 251 |
| Price | $129.95 |
| Number of chapters | 14 |
The book consists of 14 chapters, the first three covering pelvic anatomy, MRI techniques, and the role of MRI in diagnosis and staging.
The images show stages based on the most recent revision of the TNM staging system.
Transvaginal or transrectal ultrasonography offers better image resolution than transabdominal ultrasonography.
It is also useful for trainees in radiology, nuclear medicine, or oncology and for nuclear physicians and technologists.